prod:prod_dcx-login
Xpert® Xpress Flu
Qualitative detection and differentiation of influenza A and influenza B
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
10 Tests
XPRSFLU-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
Copan 3C057N (Nasopharyngeal Swab) (Pack of 50)
3C057N
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Copan 3C064N (Nasal Swab) (Pack of 50)
3C064N
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support
The Need
- Respiratory viruses, especially influenza, mutate rapidly and novel strains can emerge with little notice.
- Sensitivities of Rapid EIA Flu tests range from 50-70%1
- This genetic evolution can potentially impact the performance of molecular diagnostic tests if mutations occur within the test’s targeted regions.2
(1) CDC. Information for Clinicians on Rapid Diagnostic Testing for Influenza. https://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm#:~:text=Sensitivities%20of%20rapid%20 influenza%20diagnostic%20tests%20are%20low,culture%20or%20reverse%20transcription%20polymerase%20chain%20reaction%20%28RT-PCR%29. Accessed June 2023.
(2) Jørgensen RL, Lerche CJ, Pedersen MS, Kirkby NS, Botnen AB, Trebbien R, Nilsson-Møller S, Pinholt M,Nielsen ACY, Westh H, Lisby JG, Schneider UV. Emergence of circulating influenza A H3N2 viruses with genetic drift in the matrix gene: be alert of false-negative test results. APMIS. 2022; 130: 612–617.
(2) Jørgensen RL, Lerche CJ, Pedersen MS, Kirkby NS, Botnen AB, Trebbien R, Nilsson-Møller S, Pinholt M,Nielsen ACY, Westh H, Lisby JG, Schneider UV. Emergence of circulating influenza A H3N2 viruses with genetic drift in the matrix gene: be alert of false-negative test results. APMIS. 2022; 130: 612–617.
The Solution
Cepheid’s Xpert Xpress Flu test utilizes a multi-target approach for the detection of influenza, providing target redundancy to mitigate potential impact of genetic shift and drift on strain detection.
Accurate and reliable detection of Flu A and Flu B in as soon as 20 minutes*
Accurate and reliable detection of Flu A and Flu B in as soon as 20 minutes*
- Accurate and reliable detection of Flu A and Flu B in as soon as 20 minutes*
- Enables healthcare providers to quickly deliver targeted therapies
- Streamlines laboratory operations
* With early assay termination for positive results, full run time is approximately 30
The Impact
A single‑test workflow may support laboratory efficiency with on‑demand, random‑access testing. Combine performance with the capability to run other Xpert® tests on Cepheid’s GeneXpert® system may support laboratory workflow efficiency across overall laboratory services.
Be Proactive
Be Proactive
- Achieve rapid results to support patient management workflows
- Early assay termination option: deliver positive results in as soon as 20 minutes* and negative results in 30 minutes
- Quickly deliver results to support informed clinical decision‑making
* With early assay termination for positive results, full run time is approximately 30 mins.
Related Products
Xpert MTB/RIF
Accurate Detection of MTB and Rifampin Resistance Mutations
Xpert Xpress Strep A
Delivers accurate and timely results that optimizes fast treatment decisions